HAMPTON, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that a Phase 1a study of CDX-0159 has initiated in healthy volunteers. CDX-0159 is a humanized ...
Editors and writers independently select products unless marked Sponsored or Promoted. Sponsored content is a paid ad, while content marked Promoted is chosen by Ziff Davis leadership. We may earn an ...
A recent study tested the performance and quality of alternative test kits used for the routine detection of the COVID-19 virus. (Photo: D. Calma/IAEA) The primordial days of the COVID-19 outbreak led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback